Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Systemic Expression of Vascular Endothelial Growth Factor in Patients with Cerebral Cavernous Malformation Treated by Stereotactic Radiosurgery

  • Park, Sang-Jin (Department of Neurosurgery, Kyungpook National University Hospital) ;
  • Park, Seong-Hyun (Department of Neurosurgery, Kyungpook National University Hospital)
  • Received : 2015.12.15
  • Accepted : 2016.04.07
  • Published : 2016.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Increased expression of angiogenic factors, such as vascular endothelial growth factor (VEGF), is associated with the pathogenesis of cerebral cavernous malformations (CCMs). The purpose of this study was to investigate plasma levels of VEGF in normal subjects and in patients with CCM and to evaluate change in these levels following stereotactic radiosurgery (SRS). Methods : Peripheral venous blood was collected from 6 patients with CCM before SRS using Gamma Knife and at the 1 week, 1 month, 3month, and 6 month follow-up visits. Plasma VEGF levels were measured using commercially available enzyme-linked immunosorbent assay kits. Peripheral blood samples were obtained from 10 healthy volunteers as controls. Results : Mean plasma VEGF level of 41.9 pg/mL (range, 11.7-114.9 pg/mL) in patients with CCM at baseline was higher than that of the healthy controls (29.3 pg/mL, range, 9.2-64.3 pg/mL), without significant differences between CCM patients and controls (p=0.828). Plasma VEGF level following SRS dropped to 24.6 pg/mL after 1 week, and decreased to 18.5 pg/mL after 1 month, then increased to 24.3 pg/mL after 3 months, and 32.6 pg/mL after 6 months. Two patients suffering from rebleeding after SRS showed a higher level of VEGF at 6 months after SRS than their pretreatment level. Conclusion : Plasma VEGF levels in patients with CCM were elevated over controls at baseline, and decreased from baseline to 1 month after SRS and increased further for up to 6 months. Theses results indicated that anti-angiogenic effect of SRS might play a role in the treatment of CCMs.

Keywords

References

  1. Bobik A, Campbell JH : Vascular derived growth factors : cell biology, pathophysiology, and pharmacology. Pharmacol Rev 45 : 1-42, 1993
  2. Brauer MJ, Zhuang G, Schmidt M, Yao J, Wu X, Kaminker JS, et al. : Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies. Clin Cancer Res 19 : 3681-3692, 2013 https://doi.org/10.1158/1078-0432.CCR-12-3635
  3. Brogi E, Wu T, Namiki A, Isner JM : Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90 : 649-652, 1994 https://doi.org/10.1161/01.CIR.90.2.649
  4. Challa VR, Moody DM, Brown WR : Vascular malformations of the central nervous system. J Neuropathol Exp Neurol 54 : 609-621, 1995 https://doi.org/10.1097/00005072-199509000-00001
  5. Clatterbuck RE, Moriarity JL, Elmaci I, Lee RR, Breiter SN, Rigamonti D : Dynamic nature of cavernous malformations : a prospective magnetic resonance imaging study with volumetric analysis. J Neurosurg 93 : 981-986, 2000 https://doi.org/10.3171/jns.2000.93.6.0981
  6. Criscuolo GR, Merrill MJ, Oldfield EH : Further characterization of malignant glioma-derived vascular permeability factor. J Neurosurg 69 : 254-262, 1988 https://doi.org/10.3171/jns.1988.69.2.0254
  7. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT : The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255 : 989-991, 1992 https://doi.org/10.1126/science.1312256
  8. Ferrara N : Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55 : 15-35; discussion 35-36, 2000
  9. Houtteville JP : Brain cavernoma : a dynamic lesion. Surg Neurol 48 : 610-614, 1997 https://doi.org/10.1016/S0090-3019(96)00551-4
  10. Jung KH, Chu K, Jeong SW, Park HK, Bae HJ, Yoon BW : Cerebral cavernous malformations with dynamic and progressive course : correlation study with vascular endothelial growth factor. Arch Neurol 60 : 1613-1618, 2003 https://doi.org/10.1001/archneur.60.11.1613
  11. Kappel A, Ronicke V, Damert A, Flamme I, Risau W, Breier G : Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93 : 4284-4292, 1999
  12. Karlsson B, Kihlstrom L, Lindquist C, Ericson K, Steiner L : Radiosurgery for cavernous malformations. J Neurosurg 88 : 293-297, 1998 https://doi.org/10.3171/jns.1998.88.2.0293
  13. Kondziolka D, Lunsford LD, Flickinger JC, Kestle JR : Reduction of hemorrhage risk after stereotactic radiosurgery for cavernous malformations. J Neurosurg 83 : 825-831, 1995 https://doi.org/10.3171/jns.1995.83.5.0825
  14. Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, et al. : Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85 : 178-187, 1999 https://doi.org/10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7
  15. Little JR, Awad IA, Jones SC, Ebrahim ZY : Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg 73 : 555-559, 1990 https://doi.org/10.3171/jns.1990.73.4.0555
  16. Lunsford LD, Kondziolka D, Flickinger JC, Bissonette DJ, Jungreis CA, Maitz AH, et al. : Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 75 : 512-524, 1991 https://doi.org/10.3171/jns.1991.75.4.0512
  17. Machein MR, Kullmer J, Ronicke V, Machein U, Krieg M, Damert A, et al. : Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol 25 : 104-112, 1999 https://doi.org/10.1046/j.1365-2990.1999.00166.x
  18. Marti HH, Risau W : Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A 95 : 15809-15814, 1998 https://doi.org/10.1073/pnas.95.26.15809
  19. Monacci WT, Merrill MJ, Oldfield EH : Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264 (4 Pt 1) : C995-C1002, 1993 https://doi.org/10.1152/ajpcell.1993.264.4.C995
  20. Nagy G, Razak A, Rowe JG, Hodgson TJ, Coley SC, Radatz MW, et al. : Stereotactic radiosurgery for deep-seated cavernous malformations : a move toward more active, early intervention. Clinical article. J Neurosurg 113 : 691-699, 2010 https://doi.org/10.3171/2010.3.JNS091156
  21. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M : Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341 : 309-315, 1998 https://doi.org/10.1016/S0014-2999(97)01464-7
  22. Notelet L, Houtteville JP, Khoury S, Lechevalier B, Chapon F : Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas : an immunocytochemical study of 42 cases. Surg Neurol 47 : 364-370, 1997 https://doi.org/10.1016/S0090-3019(96)00248-0
  23. Nyary I, Major O, Hanzely Z, Szeifert GT : Histopathological findings in a surgically resected thalamic cavernous hemangioma 1 year after 40-Gy irradiation. J Neurosurg 102 Suppl : 56-58, 2005 https://doi.org/10.3171/jns.2005.102.s_supplement.0056
  24. Park SH, Hwang JH, Hwang SK : Change in plasma vascular endothelial growth factor after gamma knife radiosurgery for meningioma : a preliminary study. J Korean Neurosurg Soc 57 : 77-81, 2015 https://doi.org/10.3340/jkns.2015.57.2.77
  25. Pozzati E, Acciarri N, Tognetti F, Marliani F, Giangaspero F : Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. Neurosurgery 38 : 662-669; discussion 669-670, 1996 https://doi.org/10.1227/00006123-199604000-00006
  26. Robinson JR, Awad IA, Little JR : Natural history of the cavernous angioma. J Neurosurg 75 : 709-714, 1991 https://doi.org/10.3171/jns.1991.75.5.0709
  27. Robinson JR Jr, Awad IA, Zhou P, Barna BP, Estes ML : Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain : preliminary observations and working hypothesis. Neurol Res 17 : 49-58, 1995 https://doi.org/10.1080/01616412.1995.11740286
  28. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR : Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38 : 915-924; discussion 924-925, 1996 https://doi.org/10.1097/00006123-199605000-00011
  29. Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB : In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium : implications for mode of action. J Clin Endocrinol Metab 79 : 316-322, 1994
  30. Shweiki D, Itin A, Soffer D, Keshet E : Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 : 843-845, 1992 https://doi.org/10.1038/359843a0
  31. Sonstein WJ, Kader A, Michelsen WJ, Llena JF, Hirano A, Casper D : Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations : an immunocytochemical study. J Neurosurg 85 : 838-845, 1996 https://doi.org/10.3171/jns.1996.85.5.0838
  32. Strugar JG, Criscuolo GR, Rothbart D, Harrington WN : Vascular endothelial growth/permeability factor expression in human glioma specimens : correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 83 : 682-689, 1995 https://doi.org/10.3171/jns.1995.83.4.0682
  33. Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, et al. : Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 94 : 972-977, 2001 https://doi.org/10.3171/jns.2001.94.6.0972
  34. Terman B, Khandke L, Dougher-Vermazan M, Maglione D, Lassam NJ, Gospodarowicz D, et al. : VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11 : 187-195, 1994 https://doi.org/10.3109/08977199409046916
  35. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA : Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 48 : 359-367; discussion 367-368, 2001
  36. Wizigmann-Voos S, Breier G, Risau W, Plate KH : Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55 : 1358-1364, 1995

Cited by

  1. Vascular Abnormalities and the Role of Vascular Endothelial Growth Factor in the Epileptic Brain vol.11, pp.None, 2016, https://doi.org/10.3389/fphar.2020.00020